Cite
HARVARD Citation
McMeniman, E. et al. (2020). CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk. Journal of the European Academy of Dermatology and Venereology. pp. e797-e798. [Online].